MOO2YOU LTD

Financial Health Score: B-

Explanation: MOO2YOU LTD is a patient in post-critical recovery. After suffering a severe financial hemorrhage that resulted in negative net assets in 2023 and near-insolvency in 2024, the business has demonstrated a remarkable turnaround in 2025. The substantial profit generated has repaired the balance sheet and restored positive equity. However, the score is held back by chronically low cash reserves (a weakened immune system) and a heavy reliance on debtors for liquidity, meaning the business is still vulnerable to external shocks.

Key Vital Signs

• Net Assets (Overall Constitution): £14,342 After falling into negative territory (-£2,759 in 2023) and barely breaking even in 2024 (£1,085), the company’s net assets have recovered to a healthy positive £14,342. This indicates the business has stopped the bleeding and is rebuilding its financial muscle.
• Profit & Loss Reserve (Nutritional Intake): £13,342 This is the standout vital sign. The P&L reserve jumped from a fragile £85 in 2024 to £13,342 in 2025. This £13,257 increase represents the retained profit for the year—the primary medicine that cured the patient's previous deficit.
• Current Ratio (Blood Pressure): 1.23x Calculated as Current Assets (£57,616) divided by Current Liabilities (£46,846). A ratio above 1.0 means the company can cover its short-term debts, indicating normal blood pressure. However, 1.23x is slightly tight for comfort.
• Cash Reserves (Immune System): £6,944 Cash has improved from £2,581 in 2024, but it remains drastically lower than the £21,000-£34,000 levels seen in 2018-2021. The business is operating with a thin cash buffer, leaving it susceptible to sudden financial illness (unexpected costs or revenue dips).
• Debtors (Circulatory System): £31,606 Over half of the current assets are tied up in money owed by customers. While this is an improvement on the £49,491 owed in 2024, a large portion of the company's liquidity is currently trapped in the veins rather than flowing as cash.

Symptoms Analysis

Looking at the financial history, the patient has been on a volatile health journey:

1. Chronic Volatility (2018-2023): The business experienced a severe deterioration in health from 2018 (Net Assets of £59,489) to 2023 (Net Assets of -£2,759). This was characterized by a persistent drain on cash and an accumulation of liabilities.
2. Acute Recovery (2025): The 2025 accounts show a significant stabilization. Long-term liabilities have been reduced from £35,050 to £24,468, and provisions have been lowered from £12,435 to £9,347. The business has successfully treated its debt and provision symptoms.
3. Cash-Less Recovery: While the P&L reserve shows strong profitability, the balance sheet remains cash-light. The recovery has been funded largely by debtors paying down and the business managing its working capital, but cash generation has not kept pace with paper profitability.

Diagnosis

Post-Critical Recovery with Persistent Liquidity Weakness

The financial data reveals a business that narrowly survived a life-threatening financial event. In 2023, the company was technically insolvent (liabilities exceeded assets). In 2024, it was on life support.

The 2025 results show that the business has found a strong revenue stream or implemented drastic cost-cutting measures, generating enough profit to clear the accumulated deficit and return to positive net assets.

However, the underlying business health remains somewhat fragile. The total assets (£95,003 when combining fixed assets of £37,387 and current assets of £57,616) are heavily financed by liabilities (£80,661). Furthermore, the reliance on debtors (money owed by customers) to prop up the current assets means that if those customers fail to pay, the business could quickly relapse into distress. The going concern basis adopted by the directors is reasonable, but relies heavily on those debtors paying on time.

Prognosis

Cautiously Optimistic, provided cash flow is managed.

If the business can maintain its current profitability trajectory while converting debtors into cash, it will continue to strengthen its balance sheet. The reduction in long-term debt is a positive sign of disciplined financial management. However, with less than £7,000 in the bank, the business is one unexpected equipment breakdown or bad debt away from another crisis. The ice cream manufacturing industry is highly seasonal and susceptible to cost inflation (dairy, energy), which adds risk to this low-cash position.

Recommendations

1. Improve Cash Circulation (Debtors Management): With £31,606 tied up in debtors, implementing stricter credit control and faster collection terms is essential. Consider offering early payment discounts to customers to accelerate cash inflow and boost the "immune system."
2. Build a Cash Buffer: Aim to hold at least 3 months of operating expenses in cash to insulate the business against seasonal dips or supply chain shocks. Reinvesting some of the recent profits into a cash reserve will provide vital breathing room.
3. Continue Debt Reduction Therapy: The reduction in long-term creditors is excellent practice. Continue to systematically pay down high-interest debt to reduce the ongoing financial strain on the business.
4. Monitor Stock Health: Stocks stand at £19,066. As an ice cream manufacturer with perishable goods, ensure this stock is moving efficiently and not at risk of write-off, which would instantly reverse the recent profit gains.